Welcome back to the Class Action & MDL Roundup! This edition covers notable class actions from the second quarter of 2026. In this edition, a UK settlement ends nil–nil, pending BIPA claims are retroactive per scan, and a lodestar multiplier isn’t mathing. Plus, we have our usual coverage of lawsuits involving drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more. This edition’s video features litigation trends and developments in the fintech industry. We wrap up the…
By: Alston & Bird
By: Alston & Bird
